Impact of genetic mutations on the outcomes of allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia with antecedent myeloproliferative neoplasm.
Study #: CK15-03b
Study Status: Published
Comparison of outcomes of HCT in blast phase of BCR-ABL1-MPN with de novo AML and with AML following MDS.
Citation
Gupta V, Kim S, Hu Z-H, Liu Y, Aljurf M, Bacher U, Beitinjaneh A, Cahn J-Y, Cerny J, Copelan E, Gadalla SM, Gale RP, Ganguly S, George B, Gerds AT, Gergis U, Hamilton BK, Hashmi S, Hildebrandt GC, Kamble RT, Kindwall-Keller T, Lazarus HM, Liesveld JL, Litzow M, Maziarz RT, Nishihori T, Olsson RF, Rizzieri D, Savani BN, Seo S, Solh M, Szer J, Verdonck LF, Wirk B, Woolfrey A, Yared JA, Alyea EP, Popat UR, Sobecks RM, Scott BL, Nakamura R, Saber W.
Blood Advances. 2020, Oct 13: 4(19): 4(19):4748-4757. doi: 10.1182/bloodadvances.2020002621. Epub 2020, Oct 02. PMCID:PMC7556156.
PubMed
PMID: 33007075
Abstract